Risks and benefits of oral anticoagulants for stroke prophylaxis in atrial fibrillation according to body mass index: Nationwide cohort study of primary care records in England

BACKGROUND: Direct oral anticoagulants (DOACs) are effective and safe alternatives to warfarin for stroke prophylaxis for atrial fibrillation (AF). Whether this extends to patients at the extremes of body mass index (BMI) is unclear. METHODS: Using linked primary and secondary data, Jan 1, 2010 to N...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakao, Yoko M., Nakao, Kazuhiro, Wu, Jianhua, Nadarajah, Ramesh, Camm, A. John, Gale, Chris P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637568/
https://www.ncbi.nlm.nih.gov/pubmed/36353266
http://dx.doi.org/10.1016/j.eclinm.2022.101709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637568/
https://www.ncbi.nlm.nih.gov/pubmed/36353266
http://dx.doi.org/10.1016/j.eclinm.2022.101709

Ejemplares similares